ZEALAND PHARMA A/S — Credit Rating and Financial Key Figures

ZEALAND PHARMA A/S (CVR number: 20045078K) is a company from GLADSAXE. The company reported a net sales of 62.7 mDKK in 2024, demonstrating a decline of -81.7 % compared to the previous year. The operating profit percentage was poor at -2029.3 % (EBIT: -1272.2 mDKK), while net earnings were -1078.8 mDKK. The profitability of the company measured by Return on Assets (ROA) was -18 %, which can be considered poor and Return on Equity (ROE) was -21.1 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 90.6 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. ZEALAND PHARMA A/S's liquidity measured by quick ratio was 21.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.